News filters

DM Zone news HR Zone news Clinical Zone news DDA news Clinical guidance news Conference news Dispensary guidance news Political News NHS Statistical Reports MHRA alert Pharmacy Owners' News Scotland MORE FILTERS
England Wales UK News Drug Tariff Updates CQC MHRA News News ; England DDA news; CQC HIW Drug Information Quizzes Rurality FMD Research Brexit Supply Shortages COVID19

February 2nd 2024

Gepretix 100mg capsules alert

Exeltis UK Limited has issued an alert relating to five batches of Gepretix 100mg capsules (progesterone). The affected batches are not being recalled:   Batch number Expiry date Pack size First distributed

January 31st 2024

Pantoprazole 40mg gastro-resistant tablets alert

Cadila Pharmaceuticals (UK) Limited has issued an alert relating to a barcoding error on eight batches of pantoprazole 40mg gastro-resistant tablets. Batches are not being recalled When scanned, the EAN barcode identifies the product as bicalutamide

January 15th 2024

MHRA issues male valproate patient safety advice

Increased risk of neurodevelopmental disorders in the children they father Male patients taking valproate who are planning a family in the next year should talk to their healthcare professional about their treatment. The precautionary measure follo

Hot topics

DM Zone news HR Zone news Clinical guidance news Political News Scotland Wales Rurality Supply Shortages COVID19

January 5th 2024

Cozaar PIL alert

Missing Section 2 information Seven batches of Cozaar 100mg film-coated tablets (losartan) have an incorrect Patient Information Leaflet, manufacturer Quadrant has advised. The affected batches are: Batch No Expiry Date Pack Size First Di

December 18th 2023

Safety alerts

Posaconazole biocon 100mg gastro-resistant tablet recall One batch of posaconazole biocon 100mg gastro-resistant tablets is being recalled following routine stability testing. The affected batch is Batch Number Expiry Date Pack Size First

December 13th 2023

MHRA makes safety information recommendations

Organisations such as the DDA provide useful support MHRA should work more closely with external organisations to distribute safety communications. The consultation on how MHRA communicate with healthcare professionals to improve medicines and medi

December 12th 2023

Tresiba counselling advice

No dose change required Dispensing GP teams are alerted to new advice to support prescriptions for Tresiba (insuline degludec). By no later than 22 December 2023 all providers must ensure that patients who have been switched to Tresiba (insulin deg

DDA Suppliers Directory

Follow us

ad1 Follow us
ad1 Follow us
ad1 Follow @TheDDA1 on X